Key result
Patient-specific CT simulation guides successful Evolut FX implantation with no conduction abnormalities or significant PVL.
Why the study?
Does CT-based patient-specific computer simulation guide decision-making and predict outcomes in patients undergoing TAVI with Evolut FX?
Case Report (n=3)
No
Does CT-based patient-specific computer simulation guide decision-making and predict outcomes in patients undergoing TAVI with Evolut FX?
Answers are grounded in this paper and cite their sources.
Preprocedural CT-based computer simulation can guide device sizing and predict outcomes for the novel Evolut FX TAVI platform.
Background/Objectives: Paravalvular leak and permanent pacemaker implantation remain relevant issues after transcatheter aortic valve implantation (TAVI). Novel device development as well as adequate preprocedural device selection can contribute to optimal outcomes. Methods: Computed tomography-based patient-specific computer anatomical analysis and simulation were used in addition to standard preprocedural preparation in three of the first Evolut FX cases in our center. Procedural and follow-up echocardiographic outcomes are presented. Results: Computed tomography-based computer simulation of Evolut FX resulted in implantation of a different size in one of three cases. In three cases of severe aortic valve stenosis, procedural as well as follow-up outcomes were satisfactory and in line with the simulated results of the chosen strategy. Conclusions: Preprocedural patient-specific computer simulation predicts and guides decision-making in TAVI with the Evolut FX platform. The combination of advanced preprocedural technology and novel technologies continues to contribute to the optimization of TAVI outcomes.
No takes yet. Share an insight, caveat, or question.
Hegeman et al. (2024) conducted a case report in Severe aortic valve stenosis (n=3). CT-derived patient-specific computer simulation (FEops HEARTguide) for Evolut FX implantation was evaluated on Procedural and 6-week echocardiographic outcomes (paravalvular leak and conduction abnormalities). CT-based patient-specific computer simulation successfully guided Evolut FX implantation in three patients with severe aortic stenosis, resulting in no permanent conduction abnormalities and none-to-mild paravalvular leak at 6 weeks.
Synapse has enriched 10 related papers. Consider them for comparative context: